Alkem Laboratories shares fell 5% after Q4FY25 results showed a modest 4.2% profit rise to Rs 306 crore and margin contraction to 12.4%. While Jefferies downgraded the target to Rs 4,460 citing weak margins, Nomura maintained a ‘Buy’ with a Rs 5,430 target. The company expects high single-digit revenue growth in FY26 and rising tax rates in FY27.
Ixigo shares jumps 14%, hits 52-week high after strong Q1 results
Ixigo Share Price: Ixigo’s shares soared after reporting strong Q1FY26 results, with revenue up 73% YoY to Rs 314.5 crore and net profit increasing 27%